Novavax (NVAX) Change in Receivables (2010 - 2016)
Novavax's (NVAX) quarterly Change in Receivables came in at -$1.7 million in Q3 2016, down 243.2% year-on-year from $1.2 million in Q4 2015, and down 6500.0% quarter-over-quarter from -$26000.0 in Q2 2016.
Novavax (NVAX) Change in Receivables (2010 - 2016) Analysis & Trends
Novavax's Change in Receivables history runs 7 years deep, the most recent figure standing at -$1.7 million for Q3 2016.
- On a quarterly basis, Change in Receivables fell 243.2% year-over-year to -$1.7 million in Q3 2016; TTM through Sep 2016 was -$5.7 million, a 55.73% decrease from a year earlier, with the FY2016 full-year figure at -$2.1 million, up 75.56% from the prior year.
- Change in Receivables fell to -$1.7 million in Q3 2016 per NVAX's latest filing, from -$26000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $2.8 million in Q4 2014 and bottomed at -$6.0 million in Q2 2015.
- The 5-year median for Change in Receivables is -$240000.0 (2012), against an average of -$464894.7.
- Across the five-year window, Change in Receivables jumped 1661.25% in 2014 and sank 2569.23% in 2016, its largest moves.
- Year by year, Change in Receivables stood at -$1.5 million in 2012, then surged by 110.97% to $160000.0 in 2013, then soared by 1661.25% to $2.8 million in 2014, then plunged by 171.43% to -$2.0 million in 2015, then gained by 14.75% to -$1.7 million in 2016.
- Per Business Quant, the three latest NVAX Change in Receivables figures stand at -$1.7 million (Q3 2016), -$26000.0 (Q2 2016), and -$1.9 million (Q1 2016).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | -1.72 Mn |
| Sep 30, 2016 | -1.72 Mn |
| Jun 30, 2016 | -26,000.00 |
| Jun 30, 2016 | -26,000.00 |
| Mar 31, 2016 | -1.93 Mn |
| Mar 31, 2016 | -1.93 Mn |
| Dec 31, 2015 | -2.01 Mn |
| Dec 31, 2015 | -2.01 Mn |
| Sep 30, 2015 | -500,000.00 |
| Sep 30, 2015 | -500,000.00 |
| Jun 30, 2015 | -6.04 Mn |
| Jun 30, 2015 | -6.04 Mn |
| Mar 31, 2015 | 78,000.00 |
| Mar 31, 2015 | 78,000.00 |
| Dec 31, 2014 | 2.82 Mn |
| Dec 31, 2014 | 2.82 Mn |
| Sep 30, 2014 | -829,000.00 |
| Sep 30, 2014 | -829,000.00 |
| Jun 30, 2014 | -731,000.00 |
| Jun 30, 2014 | -731,000.00 |